“Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from Two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies”. SKIN The Journal of Cutaneous Medicine 3, no. 2 (March 11, 2019): 161. Accessed June 8, 2025. https://skin.dermsquared.com/skin/article/view/517.